Summary: HEARTCARE-B (06609) reported Revenue of 291.03M(+56.87%); Net profit attributable to owners of 60.37M(+18.51%).
ReportedYoY
Prior YearYoY
RevenueUp YoY
291.03M56.87%
185.52M--
Net profit attributable to ownersUp YoY
60.37M18.51%
50.94M--
Revenue
ReportedUnit: CNY
Net profit attributable to owners
ReportedUnit: CNY
Gross marginYoY
Unit: CNY
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2025
FY 2026
Profitability
(YoY)
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
RevenueYoY
Unit: CNY
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2025
FY 2026
Revenue
(YoY)
Cost
(YoY)
Expenses
(YoY)
Interest
(YoY)
Income Tax
(YoY)
Profit
(YoY)
Cash and cash equivalentsYoY
Unit: CNY
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2025
FY 2026
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Net cash from operating activitiesYoY
Unit: CNY
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2025
FY 2026
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Buybacks
Total repurchased
638.89K HKD
Shares repurchased
13.15K
Buyback days
1
Cumulative since 2026-11-10 (from HKEXnews next-day disclosure returns; earlier records are not included).
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows HEARTCARE-B (06609) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.